Yaohai Bio-Pharma, a contract research, development and manufacturing organization (CRDMO) that specializes in microbial expression systems, announced today that it will exhibit at BioProcess International 2026. The event will take place September 22–25, 2026 at the Hynes Convention Center in Boston, MA. Attendees are invited to visit Booth #1421 to meet the Yaohai team, learn about full-lifecycle development and manufacturing solutions, and receive a special gift prepared for conference guests.
At BioProcess International 2026, Yaohai Bio-Pharma will highlight its integrated service offerings. These include recombinant proteins, nucleic acid drugs, nanobodies, plasmid DNA, and innovative vaccines. In addition, the company supports global partners from early research and process development all the way to cGMP manufacturing and commercial supply. As a result, partners can move programs forward with scalable, regulatory-ready microbial expression platforms.
Moreover, Yaohai Bio-Pharma encourages attendees to schedule a dedicated meeting in advance. The company’s scientific and business development teams will be available at Booth #1421 to discuss project requirements, technical challenges, and tailored CRO/CDMO/MAH solutions. To book a meeting, please contact us through the company website or reach out to your Yaohai Bio-Pharma representative.
Furthermore, visitors to Booth #1421 can also pick up an exclusive Yaohai Bio-Pharma gift. We’re sending this gift as a token of appreciation to the global biopharma community. However, quantities are limited and will be available while supplies last.
For more information about Yaohai Bio-Pharma’s services, or to schedule a meeting, please visit our website and contact our business development team.
About BioProcess International 2026
BioProcess International 2026 will spotlight breakthroughs shaping the discovery, scale-up, and delivery of advanced therapies across five core pillars. The program features keynotes, sessions, workshops, and case-study forums that deliver practical strategies to improve quality, shorten timelines, and increase efficiency from development through commercialization.
About Yaohai Bio-Pharma
Yaohai Bio-Pharma is a CRDMO with extensive expertise in microbial expression systems. We focus on recombinant proteins, nucleic acid drugs, nanobodies, plasmid DNA, and innovative vaccines. From R&D to commercial manufacturing, we offer full-lifecycle solutions. Our mission is to build an open, integrated CRO/CDMO/MAH platform that supports global partners from discovery to market.
